SOX18 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL20333017	1.00	1/20
SCHEMBL26638944	0.73	1/20
SCHEMBL21530605	0.70	1/20
SCHEMBL20332761	0.70	1/20
SCHEMBL20332766	0.70	1/20
SCHEMBL26638875	0.69	1/20
SCHEMBL26744430	0.69	1/20
SCHEMBL574679	0.67	1/20
SCHEMBL20332765	0.67	1/20
SCHEMBL26745727	0.63	1/20
SCHEMBL20771694	0.58	1/20
SCHEMBL12249375	0.57	1/20
SCHEMBL8702966	0.56	1/20
SCHEMBL16113740	0.56	1/20
SCHEMBL26744786	0.55	1/20
SCHEMBL932837	0.55	1/20
SCHEMBL2129140	0.55	1/20
SCHEMBL5202410	0.55	1/20
SCHEMBL11868931	0.55	1/20
SCHEMBL16870672	0.55	1/20

Clinical trials — most relevant to SOX18 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Mechanisms of Lipodystrophy in HIV-Infected Pateints	PHASE4	COMPLETED
A Randomized Control Trial to Evaluate the Efficacy of Autologous Blood Injection Versus Local Corticosteroid Injection for Treatment of Lateral Epicondylitis	PHASE2/PHASE3	COMPLETED
New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia	PHASE2	RECRUITING
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer	PHASE1/PHASE2	SUSPENDED
SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme	PHASE2	UNKNOWN
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer	PHASE2	COMPLETED
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure	PHASE2	COMPLETED
Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)	PHASE2	COMPLETED
Stem Cell Treatment for Regeneration of the Rotator Cuff (Lipo-Cuff Study)	PHASE1	ENROLLING_BY_INVITATION
EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma	PHASE1	COMPLETED
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)	PHASE1	COMPLETED
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies	EARLY_PHASE1	UNKNOWN
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study	nan	COMPLETED
Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer	nan	COMPLETED
Micro RNA Levels in NAFLD	nan	UNKNOWN
Patient-derived Glioma Stem Cell Organoids	nan	ACTIVE_NOT_RECRUITING
Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease	nan	COMPLETED
X-chromosome Inactivation, Epigenetics and the Transcriptome	nan	COMPLETED
Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes	nan	ACTIVE_NOT_RECRUITING
Chromosomal and Morphological Structure of Mature and Immature Male Germ Cells and Recognition of IL-18 in Testicular Tissue of Azoospermic Men	nan	COMPLETED
Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development	nan	UNKNOWN
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases	nan	NOT_YET_RECRUITING
Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer	nan	RECRUITING
Role of HIF-1α in Skeletal Muscle Aging	nan	UNKNOWN
Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.	nan	UNKNOWN
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)	nan	RECRUITING
Immunophenotyping and Xist Gene in AML	nan	UNKNOWN
RORC Genetic Polymorphism of Rheumatoid Arthritis	nan	COMPLETED
COPENHAGEN Minipuberty Study	nan	UNKNOWN
MR Elastography in Intracranial Lesions: Feasibility & Accuracy	nan	ACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a SOX18 binder may also engage these)

Protein	Name	Similarity
Q9QY14	—	0.993	Q9QY14 →
P43680	—	0.993	P43680 →
Q13461	—	0.992	Q13461 →
Q63250	—	0.991	Q63250 →
Q05215	—	0.991	Q05215 →
O15522	—	0.989	O15522 →
Q9ET58	—	0.989	Q9ET58 →
Q9C009	—	0.989	Q9C009 →
A1YF08	—	0.988	A1YF08 →
O60548	—	0.988	O60548 →
Q9WUF2	—	0.988	Q9WUF2 →
O35767	—	0.988	O35767 →
Q00911	—	0.988	Q00911 →
P52952	—	0.987	P52952 →
Q60843	—	0.987	Q60843 →
Q9GLW0	—	0.987	Q9GLW0 →
P52945	—	0.987	P52945 →
A7MB34	—	0.986	A7MB34 →
P17483	—	0.986	P17483 →
Q9H2A3	—	0.986	Q9H2A3 →
A6NEQ2	—	0.986	A6NEQ2 →
Q9GL32	—	0.986	Q9GL32 →
A8MYZ6	—	0.986	A8MYZ6 →
O15370	—	0.986	O15370 →
O70220	—	0.986	O70220 →
Q9Y5W3	—	0.986	Q9Y5W3 →
Q5PQP0	—	0.986	Q5PQP0 →
Q15270	—	0.985	Q15270 →
Q8WY41	—	0.985	Q8WY41 →
Q9NP08	—	0.985	Q9NP08 →